stockrowbioAffinity Technologies, Inc. (BIAF) vs MDxHealth SA (MDXH)
- bioAffinity Technologies, Inc. BIAF 2.71 −7.51%
- MDxHealth SA MDXH 0.15 −6.25%
bioAffinity Technologies, Inc. and MDxHealth SA are both Diagnostics & Research companies. MDxHealth SA is the larger, with a market value of $14.4M against $3.3M — 4.3× the size. MDxHealth SA grew revenue faster over the last twelve months: 21.5% against −23.2%. MDxHealth SA has the higher net margin (−32.5% vs −257.3%) and the higher return on invested capital (−23.8% vs −408.7%). Across the 16 metrics below, MDxHealth SA leads on 13 and bioAffinity Technologies, Inc. on 3.
Valuation
Profitability
| Metric | BIAF | MDXH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 34.61% | 63.23% | 48.32% |
| Operating margin | (209.82%) | (18.04%) | (5.68%) |
| Net margin | (257.33%) | (32.53%) | (4.10%) |
| Free cash flow margin | (195.90%) | (5.24%) | 0.00% |
| Return on equity | (1,860.15%) | 238.67% | 0.00% |
| Return on assets | (245.51%) | (27.38%) | (6.05%) |
| Return on invested capital | (408.67%) | (23.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack